What is the appropriate management for heterotopic ossification located cephalad to the right greater trochanter after total hip arthroplasty?

Management of Heterotopic Ossification After Total Hip Arthroplasty

For heterotopic ossification cephalad to the greater trochanter after hip replacement, initial management should be conservative with observation and symptomatic treatment, reserving surgical excision only for severe cases (Brooker grade III-IV) with significant pain, functional limitation, or hip ankylosis.

Initial Assessment and Imaging

Radiographs are the first-line imaging modality to assess heterotopic ossification after THA 1. Plain radiographs effectively identify and grade heterotopic bone formation, assess for periprosthetic fractures, greater trochanter avulsions, and evaluate component positioning 1.

The key clinical question is whether the heterotopic ossification is causing symptoms or functional impairment. Most heterotopic ossification is asymptomatic and requires no intervention beyond observation.

Conservative Management

The majority of heterotopic ossification cases should be managed conservatively:

• Observation for asymptomatic or mildly symptomatic cases
• NSAIDs for pain management if symptomatic
• Physical therapy to maintain range of motion

Important caveat: Prophylaxis with NSAIDs or radiation is relevant for prevention at the time of initial surgery or revision, but has no role once heterotopic bone has already formed 2, 3.

Surgical Intervention Criteria

Surgical excision should be considered only for severe cases meeting specific criteria 4, 3:

• Brooker grade III or IV heterotopic ossification
• Significant functional limitation with severely restricted hip motion or ankylosis
• Persistent severe pain despite conservative management
• Hip deformity affecting quality of life

Surgical Approach

When surgery is indicated 4:

• Wide excision of periarticular heterotopic bone
• Selective component revision if instability is a concern (particularly acetabular revision to prevent dislocation)
• Mandatory prophylaxis to prevent recurrence:
  • Low-dose perioperative irradiation (most effective) 4
  • Alternative: NSAIDs (indomethacin or equivalent) for several weeks postoperatively 2, 3
  • Combination therapy may be considered for highest-risk cases

Critical timing consideration: While optimal timing remains unclear from the evidence, surgical excision is typically delayed until the heterotopic bone has matured (traditionally 12-18 months post-THA) to reduce recurrence risk, though this must be balanced against patient symptoms 4.

Expected Outcomes

Based on systematic review data 4:

• Range of motion typically improves after excision
• Pain relief is inconsistent and less predictable
• Recurrence rate is low (approximately 5%) with appropriate prophylaxis
• Complication rates include dislocation risk (especially without component revision when indicated)

Common Pitfalls to Avoid

• Do not operate on asymptomatic heterotopic ossification identified incidentally on radiographs
• Do not delay prophylaxis if surgical excision is performed—recurrence risk is significant without it
• Do not underestimate instability risk—consider acetabular revision in severe cases to prevent postoperative dislocation 4
• Recognize that pain relief is unpredictable—counsel patients that motion improvement is more reliable than complete pain resolution 4